IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

医学 寒冷 美罗华 胃肠病学 内科学 淋巴瘤 不利影响 人口 化疗 CD20 毒性 免疫学 环境卫生
作者
David G. Maloney,Antonio J Grillo-López,Christine A. White,David Bodkin,Russell J. Schilder,James A. Neidhart,Nalini Janakiraman,Kenneth A. Foon,Tina-Marie Liles,B.K. Dallaire,Ken Wey,Ivor Royston,Thomas A. Davis,Ronald Levy
出处
期刊:Blood [American Society of Hematology]
卷期号:90 (6): 2188-2195 被引量:1652
标识
DOI:10.1182/blood.v90.6.2188
摘要

Abstract IDEC-C2B8 is a chimeric monoclonal antibody (MoAb) directed against the B-cell–specific antigen CD20 expressed on non-Hodgkin's lymphomas (NHL). The MoAb mediates complement and antibody-dependent cell-mediated cytotoxicity and has direct antiproliferative effects against malignant B-cell lines in vitro. Phase I trials of single doses up to 500 mg/m2 and 4 weekly doses of 375 mg/m2 showed clinical responses with no dose-limiting toxicity. We conducted a phase II, multicenter study evaluating four weekly infusions of 375 mg/m2 IDEC-C2B8 in patients with relapsed low-grade or follicular NHL (Working Formulation groups A-D). Patients were monitored for adverse events, antibody pharmacokinetics, and clinical response. Thirty-seven patients with a median age of 58 years (range, 29 to 81 years) were treated. All patients had relapsed after chemotherapy (median of 2 prior regimens) and 54% had failed aggressive chemotherapy. Infusional side effects (grade 1-2) consisting of mild fever, chills, respiratory symptoms, and occasionally hypotension were observed mostly with the initial antibody infusion and were rare with subsequent doses. Peripheral blood B-cell depletion occurred rapidly, with recovery beginning 6 months posttreatment. There were no significant changes in mean IgG levels and infections were not increased over what would be expected in this population. Clinical remissions were observed in 17 patients (3 complete remissions and 14 partial remissions), yielding an intent to treat response rate of 46%. The onset of these tumor responses was as soon as 1 month posttreatment and reached a maximum by 4 months posttreatment. In the 17 responders, the median time to progression was 10.2 months (5 patients exceeding 20 months). Likelihood of tumor response was associated with a follicular histology, with the ability to sustain a high serum level of antibody after the first infusion, and with a longer duration of remission to prior chemotherapy. One patient developed a detectable but not quantifiable immune response to the antibody that had no clinical significance. IDEC-C2B8 in a dose of 375 mg/m2 weekly for 4 weeks has antitumor activity in patients with relapsed low-grade or follicular NHL. Results with this brief, outpatient treatment compare favorably with results with standard chemotherapy, and IDEC-C2B8 has a better safety profile. Further studies evaluating IDEC-C2B8 in other types of lymphoma either alone or combined with chemotherapy are warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助沉默的凤凰采纳,获得10
2秒前
ioi定中完成签到,获得积分10
2秒前
2秒前
NYM完成签到 ,获得积分10
3秒前
Li完成签到 ,获得积分10
3秒前
WZZZZ发布了新的文献求助10
3秒前
Yziii应助韦老虎采纳,获得10
4秒前
无花果应助水三寿采纳,获得10
5秒前
CYH发布了新的文献求助10
5秒前
shuyue完成签到,获得积分10
5秒前
7秒前
Leif完成签到,获得积分10
7秒前
8秒前
佩奇发布了新的文献求助10
8秒前
Bambi发布了新的文献求助10
8秒前
9秒前
ottsannn完成签到,获得积分10
10秒前
小海发布了新的文献求助10
11秒前
iCloud完成签到,获得积分10
11秒前
11秒前
12秒前
CYH完成签到,获得积分10
12秒前
12秒前
科研通AI2S应助Mrs.yang采纳,获得10
13秒前
13秒前
默默冬瓜应助ottsannn采纳,获得10
13秒前
Shilly完成签到,获得积分10
13秒前
14秒前
14秒前
科研通AI2S应助一一采纳,获得10
14秒前
明亮无颜发布了新的文献求助30
15秒前
16秒前
水三寿完成签到,获得积分20
16秒前
万能图书馆应助自由沛芹采纳,获得10
16秒前
我是老大应助吴彦祖采纳,获得10
16秒前
17秒前
firefly发布了新的文献求助20
17秒前
huangfan完成签到,获得积分20
17秒前
17秒前
EtAior发布了新的文献求助10
17秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Very-high-order BVD Schemes Using β-variable THINC Method 870
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Development of general formulas for bolted flanges, by E.O. Waters [and others] 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3255218
求助须知:如何正确求助?哪些是违规求助? 2897631
关于积分的说明 8297314
捐赠科研通 2566665
什么是DOI,文献DOI怎么找? 1393819
科研通“疑难数据库(出版商)”最低求助积分说明 652653
邀请新用户注册赠送积分活动 630272